Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.53 by 3.27 percent. This is a 15.51 percent decrease over earnings of $1.87 per share from the same period last year.
Keybanc Maintains Overweight on Applied Industrial, Lowers Price Target to $130
Keybanc analyst Ken Newman maintains Applied Industrial (NYSE:AIT) with a Overweight and lowers the price target from $140 to $130.